
Accessing high-quality healthcare no longer requires the hassle of travel or waiting in long queues. In line with the state’s digital transformation vision and Egypt’s Vision 2030 for sustainable development, which aims to make high-quality services easier for citizens to access, EVA Pharma has signed a strategic MoU with the Yodawy platform. The MoU combines the latest technology solutions with patient support programs, bringing integrated medical care to every patient’s doorstep.
The new collaboration between EVA and Yodawy covers vital specialties that touch the lives of millions of Egyptians, from cardiovascular and metabolic health to immunology and oncology, as well as pain and joint care. The collaboration goes beyond simply providing medicine. Thanks to Yodawy’s pharmacy network and innovative digital infrastructure, patients can now register seamlessly in the “EVA Pharma Patient Support Programs (PSP)” receive specialized pharmaceutical consultations and track their adherence to dosing through reminder messages and periodic calls, with safe and fast delivery of medicines guaranteed.
Because technology loses its value without qualified people, EVA Pharma has taken on the responsibility of training and developing the skills of Yodawy’s pharmacists and patient care teams, and of providing them with the latest medical evidence to ensure they deliver scientific health advice that keeps pace with the latest global standards.
Dr. Abram Wagih, Egypt Cluster Head, EVA Pharma - Egypt, said: “We don’t just manufacture medicine; we create hope and build bridges of extended care. Our deep belief in the patient’s right to complete treatment is what drove us to this strategic partnership with Yodawy.”
Dr. Abram Wagih added in press statements today: “We are breaking down traditional barriers and ensuring that our patient support programs are not just plans on paper, but a tangible daily reality that makes patients’ lives easier and ensures they continue their treatment without any interruption, backed by a medical team and pharmaceutical guidance of the highest standard.”
Dr. Abram Wagih’s remarks were echoed by Eng. Yasser Abdelgawad, Co-founder of Yodawy, who stressed that Yodawy’s vision goes beyond the classic concept of a pharmacy; it is a platform that harnesses technology to be a daily companion for patients on their journey to recovery.
Yasser Abdelgawad added: “Our collaboration today with a giant like EVA Pharma gives us an exceptional opportunity to offer an unprecedented care model in Egypt, one that begins with awareness, passes through smooth home delivery, and ends only with complete reassurance that the patient is adhering to their treatment plan.”
The collaboration also establishes strict rules for patient data privacy. The protocol guarantees full confidentiality of patient data in accordance with the Personal Data Protection Law, with no information shared without the patient’s explicit prior consent. The agreement also imposes a strict commitment to pharmacovigilance standards and immediate reporting of any medical observations to the Egyptian Drug Authority, so that patients’ health and privacy remain in safe hands.
We empower the fight for health and well being as a human right.
Subscribe for our latest news and updates
For adverse events reporting, please contact us on
PV.Report@evapharma.com